amiodarone has been researched along with Muscular Diseases in 9 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Muscular Diseases: Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The FDA revised the labels of amiodarone and simvastatin in 2002 to warn of increased risk of rhabdomyolysis, the most severe form of myopathy, when the 2 drugs are taken concomitantly in doses greater than 20 milligrams (mg) per day of simvastatin." | 3.76 | Results of a safety initiative for patients on concomitant amiodarone and simvastatin therapy in a Veterans Affairs medical center. ( Beckey, C; Hough, A; Karimi, S; Parra, D, 2010) |
| "One hundred two patients with recurrent, drug-refractory tachyarrhythmias were treated with amiodarone for nine +/- eight months (mean +/- SD) (range, one to 50 months)." | 3.67 | Unusual neurotoxicity associated with amiodarone therapy. ( Iyer, V; Meckler, RJ; Palakurthy, PR, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Packer, M | 1 |
| Prom, R | 1 |
| Umscheid, CA | 1 |
| Kasbekar, N | 1 |
| Spinler, SA | 1 |
| Karimi, S | 1 |
| Hough, A | 1 |
| Beckey, C | 1 |
| Parra, D | 1 |
| Wei, L | 1 |
| Li, XQ | 1 |
| Liu, ZH | 1 |
| Kumamoto, T | 1 |
| Fernando Roth, R | 1 |
| Itabashi, H | 1 |
| Louie, J | 1 |
| Anderson, T | 1 |
| Narahara, KA | 1 |
| Clouston, PD | 1 |
| Donnelly, PE | 1 |
| Carella, F | 1 |
| Palakurthy, PR | 1 |
| Iyer, V | 1 |
| Meckler, RJ | 1 |
1 review available for amiodarone and Muscular Diseases
| Article | Year |
|---|---|
[Amphiphilic cationic drug myopathy, drug-induced lysosomal storage lipidosis].
Topics: Aminoquinolines; Amiodarone; Animals; Anti-Arrhythmia Agents; Antimalarials; Autophagy; Cations; Chl | 2001 |
8 other studies available for amiodarone and Muscular Diseases
| Article | Year |
|---|---|
Do amiodarone and dronedarone prevent thrombo-embolic stroke by treating the atrial myopathy of patients with atrial fibrillation? A provocative hypothesis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Embolic Stroke; Humans; Muscul | 2020 |
Effect of simvastatin-amiodarone drug interaction alert on appropriate prescribing.
Topics: Amiodarone; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Drug Interactions; Humans; Hyd | 2013 |
Results of a safety initiative for patients on concomitant amiodarone and simvastatin therapy in a Veterans Affairs medical center.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Dose-Response Relationship, Drug; Drug | 2010 |
[Myopathy induced by amiodarone treatment: a case report].
Topics: Amiodarone; Female; Humans; Middle Aged; Muscular Diseases | 2007 |
Amiodarone toxicity: myopathy and neuropathy.
Topics: Amiodarone; Humans; Male; Middle Aged; Muscular Diseases; Myofibrils; Peripheral Nervous System Dise | 1990 |
Acute necrotising myopathy associated with amiodarone therapy.
Topics: Acute Disease; Aged; Aged, 80 and over; Amiodarone; Humans; Hypothyroidism; Male; Muscles; Muscular | 1989 |
Myopathy and accumulation of amiodarone.
Topics: Amiodarone; Humans; Muscles; Muscular Diseases | 1989 |
Unusual neurotoxicity associated with amiodarone therapy.
Topics: Aged; Amiodarone; Brain Diseases; Brain Stem; Female; Humans; Jaw; Male; Middle Aged; Movement Disor | 1987 |